New Delhi/IBNS: Prime Minister Narendra Modi today announced that the government has approved vaccination shots for children aged 15 and 18 years and the vaccination drive will start from January 3 (Monday).
Canberra/New Delhi/IBNS: Easing curbs on international travel, Australia has recognised Indian biotechnology company Bharat Biotech's anti-COVID-19 vaccine, Covaxin, for travel purposes.
New Delhi: Union Minister for Health and Family Welfare and Chemical and Fertilizer Mansukh Mandaviya on Sunday released the first commercial batch of COVAXIN from Chiron Behring Vaccines facility of Bharat Biotech in Ankleshwar, Gujarat.
Hyderabad/IBNS: Drug manufacturer Bharat Biotech on Friday informed that it has cancelled agreements with two Brazilian companies amid controversy over a $324 million deal with the South American country for the import of 20 million doses of the made-in-India COVID-19 vaccine-Covaxin.
New Delhi/IBNS: Brazil has announced the suspension of the $324 million contract to buy 20 million doses of Bharat Biotech's anti-COVID-19 vaccine, Covaxin, media reports said.
New Delhi/IBNS: India has raised the concerns of students vaccinated with indigenously developed Covaxin and planning a return to US educational institutions during a meeting between foreign secretary Harsh Shringla and US chargé d’ affaires Daniel Smith, said a Hindustan Times report.
New Delhi/IBNS: The Centre on Tuesday rejected claims that it could allow mixing of vaccines and reduce the Covishield vaccine schedule to a single shot, after unofficial sources informed media about the key pointers of such a plan, eliciting resistance from the medical community.
Hyderabad/IBNS: Bharat Biotech has announced that Covid-19 vaccine - COVAXIN, produced neutralising titres (concentration) against all key emerging variants tested, including the B.1.617 and B.1.1.7, first found in India and the United Kingdom.
New Delhi/IBNS: Private firms can come forward to scale up India's vaccine production and the matter is being considered, Niti Aayog (health) member Dr VK Paul said on Saturday, adding that such decisions involving transfer of technology and knowledge entail a long process.
New Delhi/UNI: Delhi Health Minister Satyendar Jain on Thursday alleged that the pharmaceutical companies Serum Institute of India and Bharat Biotech are profiteering at the expense of the common man.
Delhi/IBNS: Delhi Deputy Chief MinisterManish Sisodia has hit out at the Centre's vaccine management saying that Covaxin manufacturer BharatBiotech has refused to supply the vaccine to the national capital.
New Delhi/UNI: Congress leader and Thiruvananthapuram MP Shashi Tharoor on Sunday expressed apprehensions over the DCGI's nod for the emergency use of Bharat Biotech's COVID-19 vaccine 'Covaxin'.
New Delhi/IBNS: After Haryana Minister Anil Vij tested positive for Covid-19 on Saturday despite taking a shot of the indigenously developed Covaxin days ago, its maker Bharat Biotech in a statement said the vaccine has been designed to be effective after two doses, reported media.
Chandigarh/IBNS: Haryana Minister Anil Vij, who had taken a dose of indigenous Novel Coronavirus vaccine candidate Covaxin in its trial phase, on Saturday tested positive for Covid-19.
Hyderabad/UNI: Bharat Biotech at Genome Valley in Shamirpet on the outskirts of the city, on Saturday said that they are humbled by the visit of Prime Minister Narendra Modi to the manufacturing facility.